Literature DB >> 21832192

Genetic association of ErbB4 and human cortical GABA levels in vivo.

Stefano Marenco1, Matthew Geramita, Jan Willem van der Veen, Alan S Barnett, Bhaskar Kolachana, Jun Shen, Daniel R Weinberger, Amanda J Law.   

Abstract

NRG1-ErbB4 signaling controls inhibitory circuit development in the mammalian cortex through ErbB4-dependent regulation of GABAergic interneuron connectivity. Common genetic variation in ErbB4 (rs7598440) has been associated with ErbB4 messenger RNA levels in the human cortex and risk for schizophrenia. Recent work demonstrates that Erbb4 is expressed exclusively on inhibitory interneurons, where its presence on parvalbumin-positive cells mediates the effects of NRG1 on inhibitory circuit formation in the cortex. We therefore hypothesized that genetic variation in ErbB4 at rs7598440 would impact indices of GABA concentration in the human cortex. We tested this hypothesis in 116 healthy volunteers by measuring GABA and GLX (glutamate + glutamine) with proton magnetic resonance spectroscopy in the dorsal anterior cingulate gyrus. ErbB4 rs7598440 genotype significantly predicted cortical GABA concentration (p = 0.014), but not GLX (p = 0.51), with A allele carriers having higher GABA as predicted by the allelic impact on ErbB4 expression. These data establish an association of ErbB4 and GABA in human brain and have implications for understanding the pathogenesis of schizophrenia and other psychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21832192      PMCID: PMC3159177          DOI: 10.1523/JNEUROSCI.1529-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  29 in total

1.  Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia.

Authors:  Michael F Egan; Richard E Straub; Terry E Goldberg; Imtiaz Yakub; Joseph H Callicott; Ahmad R Hariri; Venkata S Mattay; Alessandro Bertolino; Thomas M Hyde; Cynthia Shannon-Weickert; Mayada Akil; Jeremy Crook; Radha Krishna Vakkalanka; Rishi Balkissoon; Richard A Gibbs; Joel E Kleinman; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-13       Impact factor: 11.205

2.  T1, T2 relaxation and magnetization transfer in tissue at 3T.

Authors:  Greg J Stanisz; Ewa E Odrobina; Joseph Pun; Michael Escaravage; Simon J Graham; Michael J Bronskill; R Mark Henkelman
Journal:  Magn Reson Med       Date:  2005-09       Impact factor: 4.668

3.  Neuronal and glial metabolite content of the epileptogenic human hippocampus.

Authors:  Ognen A C Petroff; Laura D Errante; Douglas L Rothman; Jung H Kim; Dennis D Spencer
Journal:  Ann Neurol       Date:  2002-11       Impact factor: 10.422

4.  Correlation of the apparent diffusion coefficient and the creatine level in early ischemic stroke: a comparison of different patterns by magnetic resonance.

Authors:  H Rumpel; J B Khoo; H M Chang; W E Lim; C Chen; M C Wong; K P Tan
Journal:  J Magn Reson Imaging       Date:  2001-03       Impact factor: 4.813

5.  Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability.

Authors:  Nicola De Stefano; Sridar Narayanan; Simon J Francis; Steve Smith; Marzia Mortilla; M Carmela Tartaglia; Maria L Bartolozzi; Leonello Guidi; Antonio Federico; Douglas L Arnold
Journal:  Arch Neurol       Date:  2002-10

6.  GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression.

Authors:  Jong H Yoon; Richard J Maddock; Ariel Rokem; Michael A Silver; Michael J Minzenberg; J Daniel Ragland; Cameron S Carter
Journal:  J Neurosci       Date:  2010-03-10       Impact factor: 6.167

7.  Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy.

Authors:  C Neill Epperson; Stephanie O'Malley; Kathryn A Czarkowski; Ralitza Gueorguieva; Peter Jatlow; Gerard Sanacora; Douglas L Rothman; John H Krystal; Graeme F Mason
Journal:  Biol Psychiatry       Date:  2005-01-01       Impact factor: 13.382

Review 8.  A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline.

Authors:  B L Miller
Journal:  NMR Biomed       Date:  1991-04       Impact factor: 4.044

9.  Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.

Authors:  D L Rothman; O A Petroff; K L Behar; R H Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

Authors:  R A Garcia; K Vasudevan; A Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  19 in total

Review 1.  Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?

Authors:  John Lisman
Journal:  Curr Opin Neurobiol       Date:  2011-11-11       Impact factor: 6.627

2.  Finding a druggable target for schizophrenia.

Authors:  Beatriz Rico
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 3.  GABA abnormalities in schizophrenia: a methodological review of in vivo studies.

Authors:  Stephan F Taylor; Ivy F Tso
Journal:  Schizophr Res       Date:  2014-10-25       Impact factor: 4.939

4.  ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children.

Authors:  Vanessa Douet; Linda Chang; Kristin Lee; Thomas Ernst
Journal:  Brain Imaging Behav       Date:  2015-03       Impact factor: 3.978

5.  GABA metabolism and its role in gamma-band oscillatory activity during auditory processing: An MRS and EEG study.

Authors:  Christine Wyss; Desmond H Y Tse; Michael Kometer; Jürgen Dammers; Rita Achermann; N Jon Shah; Wolfram Kawohl; Irene Neuner
Journal:  Hum Brain Mapp       Date:  2017-05-08       Impact factor: 5.038

6.  Role of gamma-amino-butyric acid in the dorsal anterior cingulate in age-associated changes in cognition.

Authors:  Stefano Marenco; Christian Meyer; Jan Willem van der Veen; Yan Zhang; Ryan Kelly; Jun Shen; Daniel R Weinberger; Dwight Dickinson; Karen F Berman
Journal:  Neuropsychopharmacology       Date:  2018-07-03       Impact factor: 7.853

Review 7.  Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia.

Authors:  Guillermo Gonzalez-Burgos; Raymond Y Cho; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-03-17       Impact factor: 13.382

Review 8.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

Review 9.  Synapse-specific contributions in the cortical pathology of schizophrenia.

Authors:  Saurav Seshadri; Mariela Zeledon; Akira Sawa
Journal:  Neurobiol Dis       Date:  2013-01-18       Impact factor: 5.996

10.  Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model.

Authors:  Francesco Papaleo; Feng Yang; Clare Paterson; Sara Palumbo; Gregory V Carr; Yanhong Wang; Kirsten Floyd; Wenwei Huang; Craig J Thomas; Jingshan Chen; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2016-04-27       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.